FDA Inspection 778882 — Novocol Pharmaceutical of Canada, Inc.
The FDA completed an inspection of Novocol Pharmaceutical of Canada, Inc. on April 20, 2012 in Cambridge. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 20, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cambridge (Canada)